Related Experiment Video
Updated: Jun 6, 2026

02:09
Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function
Published on: April 12, 2024
1.1K
Dyspnoea patterns in patients with advanced diseases: a functional MRI feasibility study protocol.
Jan Gaertner1,2,3, Lisa Hentsch4,5, Ivan Guerreiro6
1Palliative Care Center, Bethesda Spital AG, Basel, Switzerland jan.gaertner@unibas.ch.
BMJ Open
|February 15, 2026
Summary
This study explores using immersive virtual reality (IVR) and brain functional MRI (fMRI) to understand dyspnoea patterns in patients with advanced diseases. Findings aim to guide future research on this burdensome symptom.
Area of Science:
- Neuroscience
- Medical Imaging
- Digital Therapeutics
Background:
- Dyspnoea is a significant symptom in advanced cancer, COPD, and heart failure.
- Current dyspnoea treatments are often ineffective and disease-dependent.
- Immersive virtual reality (IVR) shows promise as a digital therapeutic for dyspnoea.
Purpose of the Study:
- To assess the feasibility of using brain functional MRI (fMRI) and IVR to identify dyspnoea patterns.
- To explore differences in fMRI-identified dyspnoea patterns across various life-limiting conditions.
- To gather preliminary data for future studies on dyspnoea mechanisms.
Main Methods:
- Observational, monocentric feasibility study in a tertiary university center.
- Participants include healthy volunteers and patients with advanced cancer, COPD, or heart failure experiencing dyspnoea.
- Brain fMRI will be conducted using IVR, with descriptive statistics for feasibility outcomes.
Main Results:
- Feasibility of the fMRI and IVR protocol will be assessed.
- fMRI patterns of dyspnoea will be analyzed across different patient groups.
- Correlations between dyspnoea and psychological symptoms will be investigated.
Conclusions:
- This study will establish the feasibility of using fMRI and IVR to study dyspnoea.
- Preliminary data will inform sample size calculations for future comparative studies.
- The findings will contribute to a better understanding of dyspnoea in life-limiting diseases.

